GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » Change In Receivables

Titan Biotech (BOM:524717) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech Change In Receivables?

Titan Biotech's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Titan Biotech's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Titan Biotech's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-1 Mil. It means Titan Biotech's Accounts Receivable increased by ₹1 Mil from Mar. 2024 to Mar. 2025 .

Titan Biotech's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹188 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Titan Biotech's Days Sales Outstanding for the three months ended in Mar. 2025 was 48.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Titan Biotech's liquidation value for the three months ended in Mar. 2025 was ₹237 Mil.


Titan Biotech Change In Receivables Historical Data

The historical data trend for Titan Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech Change In Receivables Chart

Titan Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -138.52 20.32 -45.19 24.50 -0.95

Titan Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Titan Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Biotech  (BOM:524717) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Titan Biotech's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=188.163/351.693*91
=48.82

2. In Ben Graham's calculation of liquidation value, Titan Biotech's accounts receivable are only considered to be worth 75% of book value:

Titan Biotech's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=55.583-213.043+0.75 * 188.163+0.5 * 507.229
=237

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Titan Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Biotech Business Description

Traded in Other Exchanges
N/A
Address
903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech Headlines

No Headlines